Literature DB >> 14675066

Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry.

Stefan Schaub1, John Wilkins, Tracey Weiler, Kevin Sangster, David Rush, Peter Nickerson.   

Abstract

BACKGROUND: In the last few years there has been an increasing interest in exploring the human proteome. In particular, efforts have focused on developing strategies to generate reproducible protein maps of normal cells, tissues, and biologic fluids, from which studies can then compare protein expression between different groups (e.g., healthy individuals vs. those with a specific pathologic state).
METHODS: Various extrinsic factors (instrument settings, matrix composition, urine storage post void, freeze-thaw cycles) and intrinsic factors (blood in urine, urine dilution, first-void vs. midstream urine) were analyzed with respect to their impact on urine protein profiling using surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
RESULTS: Extrinsic factors that critically influenced reproducibility and peak detection of urine protein profiling were matrix composition and instrument settings, while freeze-thaw cycles had minimal impact. Midstream urines samples did not undergo changes in their protein profile when stored for three days at 4 degrees C. Intrinsic factors that influenced normal urine protein profiling were blood in the urine and urine dilution. Female first-void urine had a significantly different ratio of proteins present compared to a midstream urine sample. Limitations of the SELDI-TOF-MS technique included ion suppression and quantification of individual proteins when protein composition was complex.
CONCLUSION: SELDI-TOF-MS offers a unique platform for high throughput urine protein profiling; however, standardization of analysis conditions is critical, and both extrinsic and intrinsic factors must be taken into account for accurate data interpretation.

Entities:  

Mesh:

Year:  2004        PMID: 14675066     DOI: 10.1111/j.1523-1755.2004.00352.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  77 in total

1.  Comparative study of seven commercial kits for human DNA extraction from urine samples suitable for DNA biomarker-based public health studies.

Authors:  Latifa El Bali; Aurélie Diman; Alfred Bernard; Nancy H C Roosens; Sigrid C J De Keersmaecker
Journal:  J Biomol Tech       Date:  2014-12

2.  SELDI-TOF derived serum biomarkers failed to differentiate between patients with beryllium sensitisation and patients with chronic beryllium disease.

Authors:  B C Tooker; R P Bowler; J M Orcutt; L A Maier; H M Christensen; L S Newman
Journal:  Occup Environ Med       Date:  2011-01-27       Impact factor: 4.402

Review 3.  The application of mass-spectrometry-based protein biomarker discovery to theragnostics.

Authors:  Jonathan M Street; James W Dear
Journal:  Br J Clin Pharmacol       Date:  2010-04       Impact factor: 4.335

Review 4.  Teaching molecular genetics: Chapter 3--Proteomics in nephrology.

Authors:  Patricia J T A Groenen; Lambert P W J van den Heuvel
Journal:  Pediatr Nephrol       Date:  2006-03-30       Impact factor: 3.714

5.  PrepMS: TOF MS data graphical preprocessing tool.

Authors:  Yuliya V Karpievitch; Elizabeth G Hill; Adam J Smolka; Jeffrey S Morris; Kevin R Coombes; Keith A Baggerly; Jonas S Almeida
Journal:  Bioinformatics       Date:  2006-11-22       Impact factor: 6.937

6.  SELDI-TOF MS of quadruplicate urine and serum samples to evaluate changes related to storage conditions.

Authors:  Avram Z Traum; Meghan P Wells; Manuel Aivado; Towia A Libermann; Marco F Ramoni; Asher D Schachter
Journal:  Proteomics       Date:  2006-03       Impact factor: 3.984

7.  Stage-specific quantitative changes in renal and urinary proteome during the progression and development of streptozotocin-induced diabetic nephropathy in rats.

Authors:  Vikram Sharma; Kulbhushan Tikoo
Journal:  Mol Cell Biochem       Date:  2013-11-27       Impact factor: 3.396

8.  Using proteomics to identify preprocedural risk factors for contrast induced nephropathy.

Authors:  Michael R Bennett; Neelima Ravipati; Gary Ross; Mai T Nguyen; Russel Hirsch; Robert H Beekman; Leon Rovner; Prasad Devarajan
Journal:  Proteomics Clin Appl       Date:  2008       Impact factor: 3.494

9.  Optimizing sample handling for urinary proteomics.

Authors:  Richard S Lee; Flavio Monigatti; Andrew C Briscoe; Zachary Waldon; Michael R Freeman; Hanno Steen
Journal:  J Proteome Res       Date:  2008-07-29       Impact factor: 4.466

Review 10.  Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease.

Authors:  Cécile Caubet; Chrystelle Lacroix; Stéphane Decramer; Jens Drube; Jochen H H Ehrich; Harald Mischak; Jean-Loup Bascands; Joost P Schanstra
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.